Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02094573
Brief Title: A Study to Evaluate the Efficacy of Brigatinib (AP26113) in Participants With Anaplastic Lymphoma Kinase (ALK)-Positive, Non-small Cell Lung Cancer (NSCLC) Previously Treated With Crizotinib

First Submitted : March 18, 2014
First Submitted that Met QC Criteria : March 21, 2014
First Posted : March 24, 2014 (Estimate)

Results First Submitted : May 26, 2017
Results First Submitted that Met QC Criteria : May 26, 2017
Results First Posted : June 21, 2017

Last Update Submitted that Met QC Criteria : February 18, 2021
Last Update Posted : March 15, 2021